Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,628
archived clinical trials in
Schizophrenia

An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Artemis Institute for Clinical Research
1139
mi
from
San Diego, CA
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Artemis Institute for Clinical Research
1139
mi
from
San Diego, CA
Click here to add this to my saved trials
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Schuster Medical Research Institute
1178
mi
from
Sherman Oaks, CA
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Schuster Medical Research Institute
1178
mi
from
Sherman Oaks, CA
Click here to add this to my saved trials
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Larkin Community Hospital Behavioral Health Services ( Site 0020)
1312
mi
from
Hollywood, FL
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Larkin Community Hospital Behavioral Health Services ( Site 0020)
1312
mi
from
Hollywood, FL
Click here to add this to my saved trials
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Atlanta Center for Medical Research
801
mi
from
Atlanta, GA
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Atlanta Center for Medical Research
801
mi
from
Atlanta, GA
Click here to add this to my saved trials
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Alexian Center for Psychiatric Research ( Site 0015)
594
mi
from
Hoffman Estates, IL
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Alexian Center for Psychiatric Research ( Site 0015)
594
mi
from
Hoffman Estates, IL
Click here to add this to my saved trials
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
CBH Health, LLC
1117
mi
from
Gaithersburg, MD
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
CBH Health, LLC
1117
mi
from
Gaithersburg, MD
Click here to add this to my saved trials
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Midwest Clinical Research Unit ( Site 0041)
746
mi
from
Dayton, OH
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Midwest Clinical Research Unit ( Site 0041)
746
mi
from
Dayton, OH
Click here to add this to my saved trials
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
InSite Clinical Research LLC
360
mi
from
DeSoto, TX
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
InSite Clinical Research LLC
360
mi
from
DeSoto, TX
Click here to add this to my saved trials
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Pillar Clinical Research, LLC
337
mi
from
Richardson, TX
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Pillar Clinical Research, LLC
337
mi
from
Richardson, TX
Click here to add this to my saved trials
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Comprehensive Clinical Development Inc.
1162
mi
from
Cerritos, CA
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Comprehensive Clinical Development Inc.
1162
mi
from
Cerritos, CA
Click here to add this to my saved trials
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Collaborative Neuroscience Network
1162
mi
from
Garden Grove, CA
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Collaborative Neuroscience Network
1162
mi
from
Garden Grove, CA
Click here to add this to my saved trials
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Behavioral Research Specialists, LLC
1167
mi
from
Glendale, CA
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Behavioral Research Specialists, LLC
1167
mi
from
Glendale, CA
Click here to add this to my saved trials
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
NRC Research Institute
1154
mi
from
Orange, CA
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
NRC Research Institute
1154
mi
from
Orange, CA
Click here to add this to my saved trials
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Collaborative Neuroscience Network, INC
1176
mi
from
Torrance, CA
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Collaborative Neuroscience Network, INC
1176
mi
from
Torrance, CA
Click here to add this to my saved trials
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Clinical Research Centers of America, LLC ( Site 0038)
1306
mi
from
Oakland Park, FL
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Clinical Research Centers of America, LLC ( Site 0038)
1306
mi
from
Oakland Park, FL
Click here to add this to my saved trials
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Aspire Health Partners ( Site 0016)
1138
mi
from
Orlando, FL
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Aspire Health Partners ( Site 0016)
1138
mi
from
Orlando, FL
Click here to add this to my saved trials
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Lake Charles Clinical Trials LLC
583
mi
from
Lake Charles, LA
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Lake Charles Clinical Trials LLC
583
mi
from
Lake Charles, LA
Click here to add this to my saved trials
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
St. Louis Clinical Trials, LLC
403
mi
from
Saint Louis, MO
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
St. Louis Clinical Trials, LLC
403
mi
from
Saint Louis, MO
Click here to add this to my saved trials
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Altea Research Institute
963
mi
from
Las Vegas, NV
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Altea Research Institute
963
mi
from
Las Vegas, NV
Click here to add this to my saved trials
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Radiant Research -CliniLabs ( Site 0037)
1225
mi
from
New York, NY
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Radiant Research -CliniLabs ( Site 0037)
1225
mi
from
New York, NY
Click here to add this to my saved trials
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Precise Research Centers
563
mi
from
Flowood, MS
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Precise Research Centers
563
mi
from
Flowood, MS
Click here to add this to my saved trials
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Psych Care Consultants Research ( Site 0025)
407
mi
from
Saint Louis, MO
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Psych Care Consultants Research ( Site 0025)
407
mi
from
Saint Louis, MO
Click here to add this to my saved trials
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Radiant Research - Atlanta
798
mi
from
Atlanta, GA
An Active-Controlled Early Phase Study of MK-8189 in Adults With Schizophrenia (MK-8189-005)
A Phase IIa, Randomized, Double-Blind, Placebo-Controlled Clinical Trial of the Efficacy and Safety of MK-8189 Using Risperidone as an Active Control in Subjects Experiencing an Acute Episode of Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Radiant Research - Atlanta
798
mi
from
Atlanta, GA
Click here to add this to my saved trials
Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia
Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Duke Univ Med Ctr
1052
mi
from
Durham, NC
Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia
Mobile Health Technology to Enhance Abstinence in Smokers With Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Duke Univ Med Ctr
1052
mi
from
Durham, NC
Click here to add this to my saved trials
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
PsychCare Consultants Research
407
mi
from
Saint Louis, MO
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
PsychCare Consultants Research
407
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Psychiatric And Behavioral Solutions
779
mi
from
Salt Lake City, UT
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Psychiatric And Behavioral Solutions
779
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Northwestern University
611
mi
from
Chicago, IL
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Northwestern University
611
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Kalamazoo Community Mental Health and Substance Abuse Services
718
mi
from
Kalamazoo, MI
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Kalamazoo Community Mental Health and Substance Abuse Services
718
mi
from
Kalamazoo, MI
Click here to add this to my saved trials
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
SPH - Kardzhali
5888
mi
from
Kardzhali,
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
SPH - Kardzhali
5888
mi
from
Kardzhali,
Click here to add this to my saved trials
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Emory University Cognitive Neurology Clinic & ADRC
802
mi
from
Atlanta, GA
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Emory University Cognitive Neurology Clinic & ADRC
802
mi
from
Atlanta, GA
Click here to add this to my saved trials
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Corrigan Mental Health Center
1437
mi
from
Fall River, MA
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Corrigan Mental Health Center
1437
mi
from
Fall River, MA
Click here to add this to my saved trials
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Creighton University
262
mi
from
Omaha, NE
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Creighton University
262
mi
from
Omaha, NE
Click here to add this to my saved trials
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
University of California San Diego Health System
1142
mi
from
San Diego, CA
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
University of California San Diego Health System
1142
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
University of Massachusetts Medical Center
1408
mi
from
Worcester, MA
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
University of Massachusetts Medical Center
1408
mi
from
Worcester, MA
Click here to add this to my saved trials
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Status: Enrolling
Updated:  12/31/1969
Michigan Clinical Research Institute
806
mi
from
Ann Arbor, MI
Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Interventional, Randomized, Double-blind, Active-controlled Study of the Efficacy of Lu AF35700 in Patients With Early-in-disease or Late-in-disease Treatment-resistant Schizophrenia
Status: Enrolling
Updated: 12/31/1969
Michigan Clinical Research Institute
806
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
HDAC Inhibitor Augmentation to Clozapine
HDAC Inhibitor Augmentation to Clozapine
Status: Enrolling
Updated:  12/31/1969
Virginia Commonwealth University
1113
mi
from
Richmond, VA
HDAC Inhibitor Augmentation to Clozapine
HDAC Inhibitor Augmentation to Clozapine
Status: Enrolling
Updated: 12/31/1969
Virginia Commonwealth University
1113
mi
from
Richmond, VA
Click here to add this to my saved trials
Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
Preventing Relapse: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE)
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles
1177
mi
from
Los Angeles, CA
Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
Preventing Relapse: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE)
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
1177
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
Preventing Relapse: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE)
Status: Enrolling
Updated:  12/31/1969
Medical College of Georgia, Department of Psychiatry
936
mi
from
Augusta, GA
Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
Preventing Relapse: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE)
Status: Enrolling
Updated: 12/31/1969
Medical College of Georgia, Department of Psychiatry
936
mi
from
Augusta, GA
Click here to add this to my saved trials
Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
Preventing Relapse: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE)
Status: Enrolling
Updated:  12/31/1969
University of Iowa College of Medicine, Psychiatry Research
429
mi
from
Iowa City, IA
Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
Preventing Relapse: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE)
Status: Enrolling
Updated: 12/31/1969
University of Iowa College of Medicine, Psychiatry Research
429
mi
from
Iowa City, IA
Click here to add this to my saved trials
Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
Preventing Relapse: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE)
Status: Enrolling
Updated:  12/31/1969
Harvard Medical School -- Massachusetts General Hospital
1443
mi
from
Boston, MA
Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
Preventing Relapse: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE)
Status: Enrolling
Updated: 12/31/1969
Harvard Medical School -- Massachusetts General Hospital
1443
mi
from
Boston, MA
Click here to add this to my saved trials
Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
Preventing Relapse: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE)
Status: Enrolling
Updated:  12/31/1969
Harvard Medical School -- Dr. John C. Corrigan Community Mental Health Center
1437
mi
from
Fall River, MA
Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
Preventing Relapse: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE)
Status: Enrolling
Updated: 12/31/1969
Harvard Medical School -- Dr. John C. Corrigan Community Mental Health Center
1437
mi
from
Fall River, MA
Click here to add this to my saved trials
Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
Preventing Relapse: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE)
Status: Enrolling
Updated:  12/31/1969
Creighton University
262
mi
from
Omaha, NE
Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
Preventing Relapse: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE)
Status: Enrolling
Updated: 12/31/1969
Creighton University
262
mi
from
Omaha, NE
Click here to add this to my saved trials
Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
Preventing Relapse: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE)
Status: Enrolling
Updated:  12/31/1969
University of New Mexico
526
mi
from
Albuquerque, NM
Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
Preventing Relapse: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE)
Status: Enrolling
Updated: 12/31/1969
University of New Mexico
526
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
Preventing Relapse: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE)
Status: Enrolling
Updated:  12/31/1969
The Zucker Hillside Hospital
1302
mi
from
Glen Oaks, NY
Preventing Relapse in Schizophrenia: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy
Preventing Relapse: Oral Antipsychotics Compared To Injectables: Evaluating Efficacy (PROACTIVE)
Status: Enrolling
Updated: 12/31/1969
The Zucker Hillside Hospital
1302
mi
from
Glen Oaks, NY
Click here to add this to my saved trials
Staccato Loxapine Single Dose PK
Safety, Tolerability, and Pharmacokinetics of a Single Dose of Staccato™ Loxapine for Inhalation in Normal, Healthy Volunteers
Status: Enrolling
Updated:  12/31/1969
Covance Clinical Research Unit Inc., d/b/a Covance GFI Research
558
mi
from
Evansville, IN
Staccato Loxapine Single Dose PK
Safety, Tolerability, and Pharmacokinetics of a Single Dose of Staccato™ Loxapine for Inhalation in Normal, Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Covance Clinical Research Unit Inc., d/b/a Covance GFI Research
558
mi
from
Evansville, IN
Click here to add this to my saved trials
Systematic Evaluation of Antiviral Medication in Schizophrenia
A Randomized Double-blind Controlled Trial of Valacyclovir Add-on Treatment of HSV Positive Early Course Schizophrenia Patients
Status: Enrolling
Updated:  12/31/1969
Wayne State University
841
mi
from
Detroit, MI
Systematic Evaluation of Antiviral Medication in Schizophrenia
A Randomized Double-blind Controlled Trial of Valacyclovir Add-on Treatment of HSV Positive Early Course Schizophrenia Patients
Status: Enrolling
Updated: 12/31/1969
Wayne State University
841
mi
from
Detroit, MI
Click here to add this to my saved trials
Systematic Evaluation of Antiviral Medication in Schizophrenia
A Randomized Double-blind Controlled Trial of Valacyclovir Add-on Treatment of HSV Positive Early Course Schizophrenia Patients
Status: Enrolling
Updated:  12/31/1969
Western Psychiatric Institute and Clinic
974
mi
from
Pittsburgh, PA
Systematic Evaluation of Antiviral Medication in Schizophrenia
A Randomized Double-blind Controlled Trial of Valacyclovir Add-on Treatment of HSV Positive Early Course Schizophrenia Patients
Status: Enrolling
Updated: 12/31/1969
Western Psychiatric Institute and Clinic
974
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Testing a New Device to Advance the Use of Social Skills Training With Mental Health Consumers and Clinicians
Social Skills Coach: An Innovative Multi-Platform Device to Address Social Impairments
Status: Enrolling
Updated:  12/31/1969
Center For Social Innovation
1435
mi
from
Needham, MA
Testing a New Device to Advance the Use of Social Skills Training With Mental Health Consumers and Clinicians
Social Skills Coach: An Innovative Multi-Platform Device to Address Social Impairments
Status: Enrolling
Updated: 12/31/1969
Center For Social Innovation
1435
mi
from
Needham, MA
Click here to add this to my saved trials
Schizophrenia and the Gut Microbiome
Schizophrenia and the Gut Microbiome
Status: Enrolling
Updated:  12/31/1969
Maryland Psychiatric Research Center
1142
mi
from
Catonsville, MD
Schizophrenia and the Gut Microbiome
Schizophrenia and the Gut Microbiome
Status: Enrolling
Updated: 12/31/1969
Maryland Psychiatric Research Center
1142
mi
from
Catonsville, MD
Click here to add this to my saved trials
Emotional Response in Psychiatric and Control Participants
Emotional Response in Psychiatric and Control Participants
Status: Enrolling
Updated:  12/31/1969
Social Ecology 1
mi
from
Irvine, CA
Emotional Response in Psychiatric and Control Participants
Emotional Response in Psychiatric and Control Participants
Status: Enrolling
Updated: 12/31/1969
Social Ecology 1
mi
from
Irvine, CA
Click here to add this to my saved trials